S

Stereotaxis Inc
AMEX:STXS

Watchlist Manager
Stereotaxis Inc
AMEX:STXS
Watchlist
Price: 2.22 USD 1.37%
Market Cap: $207.2m

Relative Value

The Relative Value of one STXS stock under the Base Case scenario is 1.59 USD. Compared to the current market price of 2.22 USD, Stereotaxis Inc is Overvalued by 28%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

STXS Relative Value
Base Case
1.59 USD
Overvaluation 28%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Multiples Across Competitors

STXS Competitors Multiples
Stereotaxis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Stereotaxis Inc
AMEX:STXS
188.3m USD 6 -7.7 -8 -7.6
US
Abbott Laboratories
NYSE:ABT
191.7B USD 4.3 29.3 16.6 22.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
179.7B USD 17.8 62.8 48 58.1
US
Stryker Corp
NYSE:SYK
139.8B USD 5.8 47.9 23.3 28.3
US
Boston Scientific Corp
NYSE:BSX
138.5B USD 7.1 49.5 29 39.4
IE
Medtronic PLC
NYSE:MDT
131.9B USD 3.8 27.8 15.5 22.5
US
Becton Dickinson and Co
NYSE:BDX
57.9B USD 2.7 34.7 12.7 21.7
DE
Siemens Healthineers AG
XETRA:SHL
47.3B EUR 2 22.2 12.6 17.8
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.2B USD 12.1 49.3 35.4 39.2
US
Edwards Lifesciences Corp
NYSE:EW
47.9B USD 8.2 35.2 25.1 27.5
US
Resmed Inc
NYSE:RMD
37.5B USD 7 25.6 18.3 20.3
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
S
Stereotaxis Inc
AMEX:STXS
Average EV/EBITDA: 23.7
Negative Multiple: -8
N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.6
9%
1.8
US
Intuitive Surgical Inc
NASDAQ:ISRG
48
24%
2
US
Stryker Corp
NYSE:SYK
23.3
13%
1.8
US
Boston Scientific Corp
NYSE:BSX
29
22%
1.3
IE
Medtronic PLC
NYSE:MDT
15.5
8%
1.9
US
Becton Dickinson and Co
NYSE:BDX
12.7
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12.6
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
35.4
14%
2.5
US
Edwards Lifesciences Corp
NYSE:EW
25.1
13%
1.9
US
Resmed Inc
NYSE:RMD
18.3
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
S
Stereotaxis Inc
AMEX:STXS
Average EV/EBIT: 29.7
Negative Multiple: -7.6
N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.7
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
58.1
25%
2.3
US
Stryker Corp
NYSE:SYK
28.3
16%
1.8
US
Boston Scientific Corp
NYSE:BSX
39.4
32%
1.2
IE
Medtronic PLC
NYSE:MDT
22.5
17%
1.3
US
Becton Dickinson and Co
NYSE:BDX
21.7
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
17.8
15%
1.2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
39.2
15%
2.6
US
Edwards Lifesciences Corp
NYSE:EW
27.5
14%
2
US
Resmed Inc
NYSE:RMD
20.3
12%
1.7